Psoriasis and beyond: targeting the IL-17 pathway

(5:50)

Unlocking the Secrets of IL17A: The Guardian of Immunity and Mediator of Inflammation

(2:)

Family Matters: The Central Role of the IL-17 Family of Cytokines in Inflammatory Disease

(21:51)

Treating Plaque Psoriasis: IL-17 and IL-23 Inhibitors

(5:19)

WCH23: IL-17 vs IL-23 Blockers – Why and When?

(3:24)

Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor

(1:53)

Cytokines and Chemokines

(15:9)

IL17 Inhibitors: An Overview

(2:43)

HPSTL 17 Royal @ HP IL 18 Select (2025.01.26)

(47:17)

Th 17 cells | Development ,differentiation and function

(5:48)

IL-17A mediated neutrophil recruitment for controlling colonisation

(3:28)

Patricia R. Taylor: IL-17 production by neutrophils ...

(13:13)

Leon Kircik, MD - What differentiates Siliq from other IL-17 biologics?

(21)

[Jesuthas Ajendra] IL-17A both initiates, via IFNγ suppression, and limits the pulmonary type-2...

(27:4)

Which is better for AxSpA? IL-17i or TNFi?

(2:35)

Countdown to Clinical Knowledge of IL-17 Inhibitors in Psoriasis

(19:28)

3.3: TNF, IL-1, and IL-17 Family Cytokines

(26:23)

lxekizumab Reduces key IL-17 and IL-23 Pathway Genes More Rapidly than Guselkumab | Lam Tsoi, PhD

(7:49)

Cytokines

(10:45)

Exploring New Targets in the IL-23/IL-17 Pathway for Psoriasis

(26:56)